Frontage (HKG:1521) recorded a net profit of $5.6 million for the nine months ended Sept. 30, up from $200,000 a year prior, a Tuesday Hong Kong bourse filing said.
The biotech firm's revenue rose 0.2% to $191.4 million in the three quarters.
Frontage (HKG:1521) recorded a net profit of $5.6 million for the nine months ended Sept. 30, up from $200,000 a year prior, a Tuesday Hong Kong bourse filing said.
The biotech firm's revenue rose 0.2% to $191.4 million in the three quarters.
Comments